Constellium Board Authorizes New $300M Share Repurchase Program
CSTM has more than doubled off its 52-week low of $7.325.
Summary
Constellium SE's Board of Directors has authorized a new share repurchase program of up to $300 million, replacing an existing program and continuing its capital allocation strategy.
Key Events · Financing and Capital Events · CSTM
-
New Share Repurchase Program Authorized
The Board of Directors has authorized a new share repurchase program of up to $300 million of the company's outstanding ordinary shares.
-
Replaces Existing Program
This new program will replace the current share repurchase program authorized in February 2024, continuing the company's capital allocation strategy.
-
Future Effective Date
The program will become effective following the 2026 Annual General Meeting of Shareholders on May 21, 2026, and will expire on December 31, 2028.
Analysis · CSTM · Manufacturing
This 8-K formalizes the company's announcement, previously reported via press release on the same day, of a significant new share repurchase program. The $300 million authorization represents a substantial commitment to returning capital to shareholders. While it replaces an existing program and becomes effective in May 2026, it signals management's confidence and a continued focus on enhancing shareholder value through reduced share count. Investors should monitor the actual execution of repurchases once the program becomes active.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 34.7% of the 1013 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CSTM was trading at $26.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $3.3B. The 52-week trading range was $7.33 to $27.41. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.